- Home
- ETON vs BRT Comparison
ETON vs BRT Comparison
Compare ETON & BRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- BRT
- Stock Information
- Founded
- ETON 2017
- BRT 1972
- Country
- ETON United States
- BRT United States
- Employees
- ETON N/A
- BRT N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- BRT Real Estate Investment Trusts
- Sector
- ETON Health Care
- BRT Real Estate
- Exchange
- ETON Nasdaq
- BRT Nasdaq
- Market Cap
- ETON 329.8M
- BRT 331.7M
- IPO Year
- ETON 2018
- BRT N/A
- Fundamental
- Price
- ETON $14.22
- BRT $18.16
- Analyst Decision
- ETON Strong Buy
- BRT Strong Buy
- Analyst Count
- ETON 3
- BRT 3
- Target Price
- ETON $27.67
- BRT $22.17
- AVG Volume (30 Days)
- ETON 248.9K
- BRT 23.1K
- Earning Date
- ETON 03-18-2025
- BRT 05-07-2025
- Dividend Yield
- ETON N/A
- BRT 5.60%
- EPS Growth
- ETON N/A
- BRT N/A
- EPS
- ETON N/A
- BRT N/A
- Revenue
- ETON $39,011,000.00
- BRT $97,274,000.00
- Revenue This Year
- ETON $107.69
- BRT N/A
- Revenue Next Year
- ETON $65.50
- BRT $5.39
- P/E Ratio
- ETON N/A
- BRT N/A
- Revenue Growth
- ETON 23.29
- BRT 1.65
- 52 Week Low
- ETON $3.03
- BRT $15.81
- 52 Week High
- ETON $18.41
- BRT $20.22
- Technical
- Relative Strength Index (RSI)
- ETON 43.84
- BRT 53.99
- Support Level
- ETON $12.73
- BRT $17.30
- Resistance Level
- ETON $15.73
- BRT $18.50
- Average True Range (ATR)
- ETON 0.93
- BRT 0.64
- MACD
- ETON -0.01
- BRT 0.02
- Stochastic Oscillator
- ETON 49.67
- BRT 50.29
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About BRT BRT Apartments Corp. (MD)
BRT Apartments Corp is a real estate investment trust company. The company is primarily focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.